While reviewing patient information, you identify that a patientreceived multiple long-acting intramuscular injections ofhaloperidol decanoate. Specifically, the patient received 11injections that were 83 mg each and each injection was administered4 weeks apart.
These injections allow the drug to be slowly absorbed into thepatient over an extended period of time. Intramuscularly injectedhaloperidol decanoate has the following pharmacokinetic parametersin this patient:
Elimination half-life: 27 days
Absorption half-life: 10 days
When will the maximum haldol decanoate concentration occur afteran injection is administered once the patient has acheived steadystate?
NOTE: Please provide your answer in units of days. Do notinclude units in your answer.
